Allergan plc (AGN) New York Stock Exchange
152.272.581.72%
CloseDecember 12, 2018

News: updated – 12-Dec 08:49


Aclaris Therapeutics: A Promising Dermatology Buy In 201811-Dec 01:44(SeekingAlpha)

Headquartered in Pennsylvania, Aclaris Therapeutics ( ACRS ) is a biopharmaceutical company focused on developing novel therapies targeting various skin and hair conditions. In the third quarter, Aclaris Therapeutics missed the consensus revenue estimate by $0.12 million but beat the GAAP …